AGEN (Agenus, Inc.) Net Profit

AGEN (Agenus Inc.) - company brandmark

Agenus (AGEN) seeks to reduce its reliance on a single oncology focus by divesting rights to legacy developments to major industry players. The efficiency of delivering critical supplies to medical centers relies on streamlined global supply chains. The current metric stands at 0.09. This chart illustrates the price action of the company, which develops innovative drugs to enhance the body's defensive functions and combat diseases.

AGEN (Agenus) Net Profit history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company Agenus Inc. (AGEN)

- price and consensus price forecast:
Stock Quotes Agenus, Inc|AGEN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Agenus, Inc|AGEN - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Agenus|AGEN - Book Capitalization|Market Capitalization to Book Value agenusbio.com|AGEN - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Agenus|AGEN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Agenus, Inc.|AGEN - Company Total Debt|Debts to Book Capitalization Agenus, Inc|AGEN - Company Long-Term Debt|Company Short-Term Indebtedness Agenus|Immediate Liquidity agenusbio.com
- net income and valuation multiples indicators:
AGEN - Net Profit
Summary company analysis:Agenus
Core merchandise of Agenus Inc

Operational business resilience is determined by the ability to generate a stable positive cash flow. This indicator measures daily net profit, separating the fundamental trend from market noise to assess asset quality. For Agenus (AGEN), this metric depends directly on the success of licensing deals for cancer immunotherapies. Positive dynamics confirm development efficiency and cash inflow. Analyzing the company's total profit allows for the timely identification of capital impairment risks.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|PHAR - Net Profit|NKTR: Net Profit|Annual Net Income upstreambio.com UPB|ZBIO (Zenas Biopharma) - Net Profit|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|KalVista Corp - Company Profit|Septerna Inc - Net Income|Net Profit pieris.com PVLA|SVRA - Company Net Income|Net Financial Result Rigel Pharma RIGL|ANAB: Net Profit|Astria Corp (ATXS) - Net Profit|ENGN (enGene Holdings Inc.) - Net Profit|RAPT - Annual Net Income|Net Profit JBIO|ACRS - Company Net Income|Company Net Income Kyverna KYTX|TLSA: Company Profit|CABA - Company Net Income|Profit After Tax VTYX|THTX: Net Profit|Avalo Therapeutics, Inc. - Final Profit|ELDN (Eledon) - Net Profit|Net Profit Climb Bio, Inc|Company Net Income Zura Bio Limited (ZURA)|ATYR (atyrpharma.com) - Final Profit|Company Net Income Adagene Inc. ADAG|IMA - Net Income|Shattuck Therapeutics - Net Profit|EQ - Net Profit|CNTB (connectbiopharm.com) - Net Income|Immunic - Final Profit|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|InflaRx GmbH (IFRX) - Net Financial Result|Company Net Income X4 Pharma (XFOR)|Net Income adicetbio.com ACET|Company Net Income Celularity CELU|INMB - Net Income|BRNS: Net Income|KZR - Net Profit|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Company Profit AKTX|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Company Net Income Q32 Bio Corp QTTB|Net Profit GOVX|Net Profit Edesa Biotech Inc (EDSA)|Net Profit IBIO (iBio Corp)|Annual Net Income Carisma Therapeutics Inc|XTL Biopharmaceuticals - Net Profit|Company Net Income Bolt Biotherapeutics|hcwbiologics.com (HCWB) - Company Net Income|Company Profit APVO|Net Income AIM|Net Profit Aditxt Corp|Company Net Income GRI Bio, Inc. (GRI)|Net Financial Result xortx.com|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|Indaptus - Net Profit|Annual Net Income BiondVax Pharmaceuticals (SCNI)|CALI: Net Profit|Company Net Income Affimed N.V. (AFMD)|Company Net Income Allakos Inc|Company Profit HOOK (HOOKIPA)|Company Net Income IGM Biosciences, Inc. (IGMS)|ITOS: Profit After Tax|Net Profit OCEA (Ocean Biomedical, Inc.)|Final Profit TCBP|Third Harmonic Bio, Inc. - Net Profit